This study found that 9.2% of patients from a New Zealand Parkinson's disease cohort carry GBA mutations. There is a significantly higher prevalence of dementia in patients carrying GBA mutations.
This New Zealand study found that reducing 12 modifiable dementia risk factors by just 15% could prevent up to 14.6% of dementia cases, with even greater benefits for Māori and Pacific peoples over a 30-year period..